Cost implications of the use of troponin I (cTnI) measurement to diagnose heart conditions
| Autor: | T. G. Trouton, Claire Scullin, M. Ryan, Michael G. Scott, James McElnay, S. Baird |
|---|---|
| Rok vydání: | 2001 |
| Předmět: |
medicine.medical_specialty
business.industry Unstable angina Health Policy Public Health Environmental and Occupational Health Pharmaceutical Science macromolecular substances Pharmacy Acute coronary insufficiency musculoskeletal system medicine.disease Internal medicine Troponin I Risk stratification cardiovascular system medicine Cardiology In patient cardiovascular diseases Myocardial infarction business Cost implications |
| Zdroj: | International Journal of Pharmacy Practice. 9:68-68 |
| ISSN: | 2042-7174 0961-7671 |
| DOI: | 10.1111/j.2042-7174.2001.tb01128.x |
| Popis: | Focal points □ The measurement of cTnI provides a sensitive test for the diagnosis of myocardial infarction and also improves risk stratification in patients with unstable angina □ The use of cTnI analyses was introduced in the study site hospital on 1 January 1999 to help diagnose heart conditions □ The use of cTnI decreased the total cost of hospitalisation in the low risk acute coronary insufficiency (ACI) diagnostic subgroup |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text